Back to search

Article

Bedaquiline resistance probability to guide treatment decision making for rifampicin-resistant tuberculosis - insights from a qualitative study

2022-09-23

Abstract excerpt

<h4>Background: </h4> Bedaquiline (BDQ) is a core drug for rifampicin-resistant tuberculosis (RR-TB) treatment. Accurate prediction of a BDQ-resistant phenotype from genomic data is not yet possible. A Bayesian method to predict BDQ resistance probability from next-generation sequencing data has been proposed as an alternative. <h4>Methods: </h4> We performed a qualitative study to investigate the decision-making...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
388ab380-0896-53f2-b9a3-4959dc0889f7
DOI
10.21203/rs.3.rs-2041161/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Bedaquiline resistance probability to guide treatment decision making for rifampicin-resistant tuberculosis - insights from a qualitative studyDOI 10.21203/rs.3.rs-2041161/v1
Select a neighboring publication to make it the new centre.